Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -3,258 | -2,389 | -1,795 | -1,142 |
| Depreciation Amortization | N/A | 41 | 162 | 124 | 81 |
| Accounts receivable | N/A | 88 | 166 | 190 | -512 |
| Accounts payable and accrued liabilities | N/A | 20 | -62 | -123 | -122 |
| Other Working Capital | N/A | 63 | 83 | -13 | -652 |
| Other Operating Activity | 0 | 2,394 | -471 | -328 | 605 |
| Operating Cash Flow | $N/A | $-652 | $-2,511 | $-1,945 | $-1,742 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 234 | -1,977 | -2,797 | -2,991 |
| PPE Investments | N/A | -1 | -5 | -4 | -4 |
| Other Investing Activity | 0 | 0 | -50 | -22 | 3 |
| Investing Cash Flow | $N/A | $233 | $-2,032 | $-2,823 | $-2,992 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 3,002 | N/A | N/A | N/A |
| Financing Cash Flow | $N/A | $3,002 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | N/A | -294 | -78 | -122 | -47 |
| Beginning Cash Position | N/A | 4,324 | 8,705 | 8,906 | 8,703 |
| End Cash Position | N/A | 6,613 | 4,084 | 4,016 | 3,922 |
| Net Cash Flow | $N/A | $2,289 | $-4,621 | $-4,890 | $-4,781 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -652 | -2,511 | -1,945 | -1,742 |
| Capital Expenditure | N/A | -1 | -5 | -4 | -4 |
| Free Cash Flow | 0 | -653 | -2,516 | -1,949 | -1,746 |